The FDA announced on Jan. 15, 2020, that Abbott Point Of Care Inc. is recalling i-STAT CG4+ cartridges because they lack FDA clearance and CLIA waived status. The agency classified the recall as Class II.
How to tell if you have it
- i-STAT CG4+ cartridge (blue), List No. 03P85-50
- UDI (01) 00054749002269
- UPC 00054749002269
The hazard
According to the FDA, the i-STAT CG4+ cartridges are not FDA cleared and do not have CLIA waived status. This means they cannot be used in facilities with a CLIA Certificate of Waiver as intended for waived tests.
Context
GovInfoNow's records show Abbott Point Of Care Inc. has had 8 other recalls since Sept. 12, 2017. Other recent recalls include the Abbott i-STAT G3+ Cartridges recall on April 1, 2026, and the Abbott i-STAT EG7+ Cartridge Recall on Aug. 21, 2025. Similar products recalled recently include the QUCARE Total Cholesterol Test on April 2, 2026, and the Bisaf Strep A Self-Test on Dec. 19, 2025.